###begin article-title 0
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 79 84 <span type="species:ncbi:10090">Mouse</span>
Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer
###end article-title 0
###begin p 1
Conceived and designed the experiments: JK YY. Performed the experiments: YY MR AH EW. Analyzed the data: JK IW YY MR EW JM CK. Contributed reagents/materials/analysis tools: FD KI MW GP. Wrote the paper: JK YY.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related death in Western countries. Developing more effective NSCLC therapeutics will require the elucidation of the genetic and biochemical bases for this disease. Bronchioalveolar stem cells (BASCs) are a putative cancer stem cell population in mouse models of oncogenic K-ras-induced lung adenocarcinoma, an histologic subtype of NSCLC. The signals activated by oncogenic K-ras that mediate BASC expansion have not been fully defined.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras,</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 352 411 352 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phosphatase and tensin homologue deleted from chromosome 10</italic>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
We used genetic and pharmacologic approaches to modulate the activity of phosphatidylinositol 3-kinase (PI3K), a key mediator of oncogenic K-ras, in two genetic mouse models of lung adenocarcinoma. Oncogenic K-ras-induced BASC accumulation and tumor growth were blocked by treatment with a small molecule PI3K inhibitor and enhanced by inactivation of phosphatase and tensin homologue deleted from chromosome 10, a negative regulator of PI3K.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 121 129 <span type="species:ncbi:9606">patients</span>
We conclude that PI3K is a critical regulator of BASC expansion, supporting treatment strategies to target PI3K in NSCLC patients.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in Western countries and its incidence is rising in Asia. Once it has metastasized, there are no curative therapies for NSCLC. A better understanding of the pathogenesis and risk factors for this disease will contribute not only to improvements in early detection and prevention but also to the development of more effective therapies for it.
###end p 9
###begin p 10
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 72 75 72 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-AvielRonen1">[1]</xref>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 375 378 375 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Mori1">[2]</xref>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 606 609 606 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Fisher1">[3]</xref>
###xml 610 613 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Johnson1">[7]</xref>
###xml 506 511 <span type="species:ncbi:10090">Mouse</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
Approximately 10% of NSCLC specimens carry activating mutations in K-ras[1]. The histologic subtype of NSCLC that most frequently has K-ras mutations is adenocarcinoma; 30% of adenocarcinomas have these mutations. K-ras mutations have also been identified in atypical adenomatous hyperplasia (AAH) lesions, which are thought to precede the development of lung adenocarcinoma [2]. A growing body of evidence indicates that K-ras mutations are important in the initiation of lung adenocarcinoma development. Mouse models have been developed that express mutant K-ras conditionally, somatically, or inducibly [3]-[7]. These mice develop AAH lesions rapidly and with high penetrance, and a subset of these lesions progress to adenocarcinomas.
###end p 10
###begin p 11
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 211 214 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 356 359 356 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Kim1">[8]</xref>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 544 545 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 628 631 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Rawlins1">[9]</xref>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL</sup>
###xml 780 785 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 793 796 793 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Jackson1">[5]</xref>
###xml 877 880 877 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Kim1">[8]</xref>
###xml 914 919 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 965 968 965 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Kim1">[8]</xref>
###xml 100 106 <span type="species:ncbi:10090">murine</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
###xml 1298 1306 <span type="species:ncbi:9606">patients</span>
A candidate lung cancer progenitor cell (bronchioalveolar stem cell or BASC) has been identified in murine models of K-ras-induced lung cancer. BASCs have a specific pattern of stem cell marker expression (Sca-1pos CD34pos CD45neg Pecamneg), are located at the terminal bronchi, and have the capacity to self-renew and undergo multi-linage differentiation [8]. These cells may be the same as the variant Clara (or ClaraV) cells, which are located adjacent to clusters of neuroendocrine bodies in bronchi and bronchioles. Similar to BASCs, ClaraV cells are capable of restoring the Clara cell population after naphthalene injury [9]. After intra-nasal installation of adenoviral Cre into KrasLSL mice, which develop lung adenocarcinoma due to activation of a conditional oncogenic K-ras allele [5], BASCs rapidly proliferate prior to the development of histologic abnormalities [8]. The BASCs in these mice contain K-ras mutations identical to those found in tumors [8]. On the basis of this evidence, BASCs are postulated to be progenitors of lung adenocarcinoma in mice. The biochemical signals that initiate the expansion of this cellular population have not been fully elucidated. This deficiency is important given that the elucidation of these signals might lead to better treatment for NSCLC patients.
###end p 11
###begin p 12
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-CourtoisCox1">[10]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-CourtoisCox1">[10]</xref>
###xml 916 975 916 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phosphatase and tensin homologue deleted from chromosome 10</italic>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1057 1061 1057 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Eng1">[11]</xref>
###xml 1062 1066 1062 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Forgacs1">[15]</xref>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
Premalignant lesions typically undergo a transient expansion followed by programmed senescence, and only a minority of early lesions progresses to a fully transformed state. In the case of Ras-dependent cancer mouse models, the programmed senescence of premalignant lesions is activated by mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling, which inhibits Ras through feed-back pathways involving increased expression of SPROUTY proteins, Ras GTPase activating proteins, and mitogen-activated protein kinase phosphatase-3 [10]. The senescence program in premalignant lesions can be blocked by phosphatidylinositol 3-kinase (PI3K) activation [10], indicating that PI3K is a crucial determinant of the malignant progression of these lesions. In fact, PI3K signaling is constitutively activated in NSCLC cells through inactivating somatic mutations in, or epigenetic silencing of, phosphatase and tensin homologue deleted from chromosome 10 (Pten), a lipid phosphatase that negatively regulates the PI3K signaling cascade [11]-[15].
###end p 12
###begin p 13
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras-</italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL</sup>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
In this study, we evaluated the importance of PI3K in regulating the expansion of BASCs in two genetic mouse models of oncogenic K-ras-induced lung cancer. The oncogenic K-ras alleles in these models are activated somatically in one (KrasLA1) and conditionally in the other (KrasLSL) (5, 7). We found increased numbers of BASCs in these mice relative to those of wild-type littermates. BASC expansion and malignant progression in the lung were attenuated by pharmacologic inhibition of PI3K and enhanced by genetic inactivation of Pten. We speculate on the basis of these findings that pharmacologic strategies to inhibit PI3K will be useful in the prevention and treatment of NSCLC.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
PX-866 inhibits lung tumorigenesis in KrasLA1 mice
###end title 15
###begin p 16
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Johnson1">[7]</xref>
###xml 658 664 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 682 683 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 707 708 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 730 739 716 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g001">Figure 1A</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
We postulated that PI3K is required for malignant progression in lung cancer and tested this hypothesis by using KrasLA1 mice as a model of lung tumorigenesis. Several weeks after birth, KrasLA1 mice exhibit multifocal AAH lesions that, by 2-3 months of age, coalesce into solid or papillary adenomas, which enlarge and undergo histologic transformation into adenocarcinomas by 6-8 months [7]. We first evaluated the expression of PI3K (p110alpha and beta isoforms) in lung tissues at different stages of tumorigenesis (AAH, adenoma, or adenocarcinoma). These PI3K isoforms were detected and their abundance increased with malignant progression (AAH lesions versus adenocarcinomas: P = 0.006 for p110alpha; P<0.001 for p110beta) (Figure 1A).
###end p 16
###begin title 17
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
PI3K promotes tumorigenesis in KrasLA1 mice.
###end title 17
###begin p 18
###xml 513 514 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1172 1173 1164 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
(A) PI3K expression increases with malignant progression. Representative immunohistochemical staining of lesions in the tissue microarray and their quantification in adjacent bar graphs. Calibration bar in lower right panel represents 100 mum. Scores of mixed (solid/papillary) adenomas are included in bar graphs but not in PI3K staining images. (B) PI3K is required for tumor growth. Mean changes in tumor multiplicity and volume determined by micro-computed tomography performed before and after treatment. (* P<0.05 compared to vehicle). (C) PX-866 inhibits PI3K in lung tissues. Western blotting of Ser473-phosphorylated AKT (P-AKT) and Ser21/9-phosphorylated GSK3 (P-GSK3alpha/beta) in whole lung lysates from mice (n = 7 in each treatment cohort). Positions of molecular weight markers are indicated on the left. (D) PX-866 decreases tumor cell proliferation. Representative immunohistochemical staining of Ser28-phosphorylated histone H3 (P-H3) in adenomas in the tissue microarray (x 20 magnification, areas with positive cells encircled) and quantification of staining in 16 lesions from vehicle-treated mice and 4 lesions from PX-866-treated mice (bar graph, * P<0.05 compared to vehicle). Inset illustrates encircled cells at x40 magnification. Calibration bars represent 200 mum.
###end p 18
###begin p 19
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Ihle1">[16]</xref>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g001">Figure 1B</xref>
###xml 413 422 413 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g001">Figure 1C</xref>
###xml 544 553 544 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g001">Figure 1D</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
Based on its increased abundance in fully transformed cells, we next sought to determine whether PI3K was required for tumor growth. Treatment of K-rasLA1 mice with PX-866, a PI3K inhibitor [16], decreased lung lesion volume and multiplicity (Figure 1B). This was accompanied by reductions in PI3K activity as shown by western blotting of whole-lung lysates for phosphorylated AKT and glycogen synthase kinase-3 (Figure 1C). Tumor cells underwent a reduction in proliferation caused by PX-866 based on intra-lesional phosphorylated histone H3 (Figure 1D) but exhibited no biochemical evidence of apoptosis as shown by western blotting for cleaved caspase-3 and Poly (ADP-ribose) polymerase (data not shown). Thus, treatment with a PI3K antagonist profoundly inhibited the growth of these early lesions.
###end p 19
###begin title 20
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
BASCs are highly sensitive to PX-866 in vivo and in vitro
###end title 20
###begin p 21
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 259 267 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g002">Figure 2</xref>
###xml 299 302 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Kim1">[8]</xref>
###xml 387 390 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 578 584 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 589 592 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 595 603 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g002">Figure 2</xref>
###xml 648 651 648 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 807 815 803 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g003">Figure 3</xref>
###xml 938 941 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 1302 1303 1298 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1321 1327 1317 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 1345 1353 1341 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g004">Figure 4</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
We next determined whether the anti-tumor effect of PX-866 in KrasLA1 mice was partly due to inhibition of BASC expansion. At the terminal bronchi, a subset of epithelial cells expressed both clara cell specific protein (CCSP) and surfactant protein-C (SPC) (Figure 2), which is a hallmark of BASCs [8]. Quantification of dual-positive cells in wild-type mice (with 83 bronchi) and K-rasLA1 mice (with 66 bronchi) revealed that no wild-type mice had more than 3 BASCs per terminal bronchus, whereas a subset of terminal bronchi in K-rasLA1 mice had 4 to 7 (P = 0.042, wild-type versus KrasLA1) (Figure 2). Thus, a subset of terminal bronchi in KrasLA1 mice had BASC expansion. Furthermore, triple immunofluorescence studies revealed that BASCs expressed p110alpha and had detectable phosphorylation of AKT (Figure 3), a downstream mediator of PI3K, providing evidence of PI3K activation in these cells. Using tissue sections from the KrasLA1 mice treated with PX-866 (with 88 terminal bronchi) or vehicle (with 81 terminal bronchi), we determined the number of BASCs per terminal bronchus in the treatment groups. The vehicle-treated mice had a subset of terminal bronchi with 4 to 7 BASCs per terminal bronchus, whereas none of the PX-866-treated mice had more than three BASCs per terminal bronchus (P = 0.025, vehicle versus PX-866-treated) (Figure 4).
###end p 21
###begin title 22
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
KrasLA1 mice have an accumulation of BASCs at terminal bronchi.
###end title 22
###begin p 23
Immunofluorescent staining to detect cells at terminal bronchi that co-express CCSP and SPC. Encircled BASCs in top panels (x10 magnification) illustrated in lower panels at higher magnification (x40). Bar graph indicates percentages of terminal bronchi with the indicated numbers of BASCs. Calibration bars in images of H&E stained tissues represent 50 mum.
###end p 23
###begin title 24
BASCs express p110alpha and have Ser473-phosphorylated AKT.
###end title 24
###begin p 25
Immunofluorescent staining of tissue sections to detect triply stained (CCSP/SPC/p110alpha or pAKT) cells at terminal bronchi. BASCs encircled (x40 magnification). Calibration bar in lower right panel represents 50 mum.
###end p 25
###begin title 26
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
PX-866 treatment decreases BASC numbers in KrasLA1 mice.
###end title 26
###begin p 27
Immunofluorescent staining to detect cells at terminal bronchi that co-express CCSP and SPC. Encircled BASCs in top panels (x10 magnification) illustrated in lower panels at higher magnification (x40). Bar graph indicates percentages of terminal bronchi with the indicated numbers of BASCS. Calibration bars in images of H&E stained tissues represent 50 mum.
###end p 27
###begin p 28
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g005">Figure 5A</xref>
###xml 333 342 333 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g005">Figure 5B</xref>
###xml 425 434 425 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g005">Figure 5C</xref>
###xml 466 469 466 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Kim1">[8]</xref>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g005">Figure 5D</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
To determine whether PX-866 had direct effects on KrasLA1-derived BASCs, we used primary BASC cultures, which were isolated from the lungs of KrasLA1 mice by sorting for cells that were Sca-1pos, CD34pos, CD45neg, and CD31neg. These sorted cells co-expressed CCSP and SPC (Figure 5A), formed colonies when plated on feeder cultures (Figure 5B), and exhibited multi-potential differentiation capacity when plated in matrigel (Figure 5C), which are hallmarks of BASCs [8]. PX-866 treatment led to a prominent decrease in BASC colony forming activity (Figure 5D), indicating that PX-866 had a direct effect on BASCs.
###end p 28
###begin title 29
###xml 31 40 31 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro.</italic>
PX-866 inhibits BASC expansion in vitro.
###end title 29
###begin p 30
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 722 725 720 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 729 732 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 752 755 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 759 762 757 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 779 782 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 786 789 784 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
(A) Sorted cells co-express SPC and CCSP. KrasLA1 whole lung tissues were dissociated and sorted to isolate Sca-1pos CD45neg CD31neg CD34pos cells (P4 and P5 in left and middle panels, respectively), which were subjected to immunofluorescent staining (x40 magnification, right panel). Calibration bar in far right panel represents 10 mum. (B) BASCs form colonies when plated on feeder cultures. Photograph of colony (x10 magnification) formed upon initial plating (P1) and passage 2 (P2). Calibration bar in panel on right represents 50 mum. (C) BASCs differentiate when plated in matrigel. Cells were stained after 7 d in matrigel (x10 magnification) and the numbers of cells with features of alveolar type II cells (CCSPneg SPCpos), clara cells (CCSPpos SPCneg), or BASCs (CCSPpos SPCpos) were counted and expressed as the percentages of the total 158 counted cells in a pie chart. Examples of cells with features of ATII cells (ATII) and clara cells (CC) are indicated. Calibration bar in far right panel represents 50 mum. (D) PX-866 inhibits BASC colony formation. Photographs (x10 magnification) and quantification of colonies per well (5 wells per condition) formed after 6 d in the presence or absence of PX-866. Calibration bar in panel on right represents 50 mum.
###end p 30
###begin title 31
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
Pten deficiency enhances oncogenic K-ras-induced BASC accumulation
###end title 31
###begin p 32
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 193 199 193 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP</italic>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Lesche1">[17]</xref>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 402 407 402 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCSP</italic>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Iwanaga1">[18]</xref>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL</sup>
###xml 681 685 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 676 685 676 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras<sup>G12D</sup></italic>
###xml 754 757 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Jackson1">[5]</xref>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 842 855 842 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 861 866 853 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 887 892 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 898 903 890 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 909 914 901 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 922 926 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 952 957 944 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 974 987 966 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 993 998 977 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 1004 1009 988 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 1033 1042 1017 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 1048 1051 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">Mice</span>
As another approach to evaluating the role of PI3K in BASC expansion, we inactivated Pten, a negative regulator of PI3K, in CCSP-expressing cells. Pten was genetically inactivated by using Ptenflox/+ mice, which have a Pten allele that contains LoxP sites surrounding the PTEN phosphatase domain encoded by exon 5 [17]. Pten was recombined specifically in the lung by interbreeding these mice with CCSPCre/+ mice, which express Cre under the control of the CCSP gene [18]. In addition, we evaluated whether Pten inactivation cooperated with oncogenic K-ras to promote BASC expansion. Pten-deficient mice were interbred with K-rasLSL mice, in which the expression of oncogenic K-rasG12D is controlled by a removable transcription termination STOP element [5]. Using this approach, mice were generated with bronchi that are Pten-deficient (PtenDelta5/Delta5; CCSPCre/+), express oncogenic K-ras (KrasLox/+; CCSPCre/+), have Pten deficiency and oncogenic K-ras expression (PtenDelta5/Delta5; KrasLox/+; CCSPCre/+), or have neither (Ptenflox/flox; CCSP+/+). Mice were sacrificed at 4 weeks or 12 weeks, and their lung tissues were subjected to immunofluorescence studies to quantify BASCs.
###end p 32
###begin p 33
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 173 186 173 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 192 197 184 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 203 208 195 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 241 246 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 264 269 256 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 275 280 267 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 283 291 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g006">Figure 6</xref>
###xml 365 369 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 392 405 384 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 411 416 395 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 498 507 482 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 513 516 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 519 527 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g007">Figure 7</xref>
###xml 573 586 557 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 592 597 568 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 603 608 579 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 629 634 605 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 640 645 616 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 669 673 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 733 738 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 740 741 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 755 768 731 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 774 779 742 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 785 790 753 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 790 796 758 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 801 806 769 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 812 817 780 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 820 828 788 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g007">Figure 7</xref>
###xml 902 905 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 909 912 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 977 990 945 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 996 1001 956 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 1007 1012 967 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 1137 1142 1097 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 1148 1153 1108 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 1160 1168 1120 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002220-g008">Figure 8</xref>
###xml 1188 1192 1148 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1232 1237 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
###xml 1154 1158 <span type="species:ncbi:10090">mice</span>
As expected, triple immunofluorescence staining (CCSP/SPC/PTEN) revealed loss of PTEN expression in BASCs from mice that were both Pten-deficient and K-ras-transformed (PtenDelta5/Delta5; KrasLox/+; CCSPCre/+) but not in mice that were only K-ras-transformed (KrasLox/+; CCSPCre/+) (Figure 6). Quantification of BASCs per terminal bronchus at 4 weeks revealed that Pten-deficiency alone (PtenDelta5/Delta5; CCSPCre/+) was not sufficient to change BASC numbers relative to that of control mice (Ptenflox/flox; CCSP+/+) (Figure 7). However, comparison of BASC numbers in PtenDelta5/Delta5; KrasLox/+; CCSPCre/+ mice to that of KrasLox/+; CCSPCre/+ mice demonstrated that Pten deficiency strikingly enhanced BASC expansion by oncogenic K-ras (P = 0.006, PtenDelta5/Delta5; KrasLox/+; CCSPCre/+versus KrasLox/+; CCSPCre/+) (Figure 7). In addition to these findings at the terminal bronchi, clusters of CCSPpos SPCpos cells were observed in the bronchioles and small bronchi of PtenDelta5/Delta5; KrasLox/+; CCSPCre/+ mice; these cell clusters were evident as early as 4 weeks of age and were not present in the bronchi or bronchioles of KrasLox/+; CCSPCre/+ mice (Figure 8). We conclude that Pten inactivation cooperated with oncogenic K-ras to enhance BASC accumulation.
###end p 33
###begin title 34
###xml 42 55 42 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 61 66 53 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 72 77 64 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Loss of PTEN expression in BASCs from PtenDelta5/Delta5; KrasLox/+; CCSPCre/+ mice.
###end title 34
###begin p 35
Immunofluorescent staining of tissue sections to detect triply stained (CCSP/SPC/PTEN) cells at terminal bronchi. BASCs (encircled) illustrated at x10 magnification. Calibration bar in lower right panel represents 100 mum.
###end p 35
###begin title 36
###xml 42 55 42 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 61 66 53 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 72 77 64 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
BASC expansion at terminal bronchi of PtenDelta5/Delta5; KrasLox/+; CCSPCre/+ mice.
###end title 36
###begin p 37
Immunofluorescent staining to detect cells at terminal bronchi that co-express CCSP and SPC. BASCs (encircled) illustrated at x40 magnification. Bar graph indicates percentages of terminal bronchi with the indicated numbers of BASCS. Calibration bar in lower right panel represents 100 mum.
###end p 37
###begin title 38
###xml 53 66 53 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;5/&#916;5</sup>
###xml 72 77 64 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 83 88 75 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 106 111 98 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lox/+</sup>
###xml 117 122 109 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
BASCs identified in small bronchi/bronchioles of PtenDelta5/Delta5; KrasLox/+; CCSPCre/+ mice but not KrasLox/+; CCSPCre/+ mice.
###end title 38
###begin p 39
Immunofluorescent staining to detect cells that co-express CCSP and SPC. BASCs (encircled) illustrated at x10 magnification. Bar graph illustrates percentages of bronchi with the indicated numbers of BASCS. Calibration bar in lower right panel represents 100 mum.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 367 375 367 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Iwanaga1">[18]</xref>
###xml 1218 1226 1218 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Eramo1">[19]</xref>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1152 1160 <span type="species:ncbi:9606">patients</span>
###xml 1321 1330 <span type="species:ncbi:10090">nude mice</span>
Here we report that PI3K was required for BASC expansion initiated by oncogenic K-ras and, when constitutively activated by Pten inactivation, PI3K cooperated with oncogenic K-ras in this process. This conclusion was based on findings from experiments that incorporated pharmacologic and genetic approaches to target PI3K in two different genetic mouse models and an in vitro model. We have previously reported that Pten inactivation cooperates with oncogenic K-ras to accelerate lung tumorigenesis, causing lung tumors that are more histologically advanced and more rapidly obstruct bronchial lumina and replace alveolar spaces than those of mice with oncogenic K-ras alone [18]. Together, these findings raise the possibility that PI3K promoted lung tumorigenesis through its effects on BASCs. However, conclusive evidence in this regard will require proof that adenocarcinomas arise from BASCs. Transplantation studies to determine whether BASC injections are sufficient to recapitulate lung adenocarcinoma development in mice have thus far not been reported. A stem cell population has been identified in the lungs of mice and in tumors from NSCLC patients that expresses CD133, exhibits stem cell characteristics in vitro (forms spheres and can be induced to undergo terminal differentiation), and is tumorigenic in nude mice [19]. Although certain features of that stem cell population are similar to those of BASCs (i.e. response to naphthalene-induced lung injury), their relationship remains to be elucidated.
###end p 41
###begin p 42
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Yanagi1">[20]</xref>
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</sup>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Yilmaz1">[21]</xref>
###xml 1148 1151 1148 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Rawlins1">[9]</xref>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
When initiated during embryogenesis, conditional Pten inactivation in the lung leads to hypoxia and perinatal death, indicating that Pten expression is required for normal lung development [20]. In this study, Cre expression in CCSPCre mice began at postnatal day 4, allowing us to evaluate Pten's role in maintaining lung function after birth. Although we can not exclude the possibility that subtle changes in lung function occurred, the Pten-deficient mice in this study had no obvious alterations in their lung structure and exhibited no morbidity at up to 12 months of age, suggesting that, after birth, lung tissues can function normally without Pten. This apparent resilience of lung tissues to Pten deficiency stands in contrast to adult hematopoietic stem cells, which are depleted within 40 days after inactivation of Pten[21], indicating that the self-renewal capabilities of hematopoietic stem cells can not be maintained in the absence of PTEN's negative growth regulatory signals. Although the reasons for this difference are not clear, it may be related in part to the relative infrequency with which lung stem cells normally divide [9].
###end p 42
###begin p 43
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA2</sup>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CA</italic>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA2</sup>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CA</italic>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Gupta1">[22]</xref>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 655 658 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 899 903 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Iwanaga1">[18]</xref>
###xml 918 922 918 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 955 960 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 1126 1136 1126 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten, Egfr</italic>
###xml 1142 1148 1142 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CA</italic>
###xml 1163 1172 1163 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Angulo1">[ref. 23]</xref>
###xml 1238 1243 1238 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 1324 1329 1324 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 1461 1466 1461 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 1630 1633 1630 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Fisher1">[3]</xref>
###xml 1634 1637 1634 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Johnson1">[7]</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
PI3K has been reported to play an important role in tumorigenesis initiated by oncogenic K-ras. KrasLA2 mice that have a knock-in PIK3CA mutation that blocks the interaction of PI3K with K-ras develop far fewer lung tumors than do KrasLA2 mice with wild-type PIK3CA[22], indicating a key role for PI3K as a downstream mediator of K-ras. Corroborating this point, we found that PX-866 treatment inhibited lung tumor growth in KrasLA1 mice. However, based on other findings reported here, the importance of PI3K in K-ras-induced lung tumorigenesis may not be restricted to its role as a downstream mediator of K-ras. First, PI3K expression increased as KrasLA1 lung tissues underwent malignant progression from AAH to adenocarcinoma, suggesting that PI3K was activated in these histologically advanced lesions in part through K-ras-independent mechanisms. Second, findings reported here and elsewhere [18] indicate that Pten inactivation enhanced oncogenic K-ras-induced lung tumorigenesis in mice. Extrapolating from these findings, somatic mutations in NSCLC cells involving genes that regulate PI3K-dependent signaling (i.e. Pten, Egfr, and PIK3CA, among others [ref. 23]) may transform these cells in part by cooperating with oncogenic K-ras. The potential importance of secondary somatic mutations in promoting oncogenic K-ras-induced lung tumorigenesis is illustrated by the long latencies of adenocarcinomas that arise in mice engineered to express mutant K-ras, which develop lung lesions rapidly and with high penetrance, but only a fraction of the lesions progress into adenocarcinomas and require several months to do so [3]-[7].
###end p 43
###begin p 44
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Yanagi1">[20]</xref>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Iwanaga1">[18]</xref>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 522 526 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 856 861 856 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 925 930 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K-ras</italic>
###xml 935 939 935 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 1112 1116 <span type="species:ncbi:10090">mice</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
Findings reported here differed from those reported previously in a different strain of mice that undergo conditional Pten deletion induced by SPC-driven Cre expression [20]. In that report, Pten inactivation was sufficient to increase BASC numbers and induce lung tumors, which stands in contrast to findings presented here and elsewhere [18] that Pten deficiency is not sufficient to increase BASC numbers or induce lung tumors. That previous report also differed with respect to the genetic events that cooperated with Pten deficiency. In that study, Pten inactivation accelerated lung tumorigenesis induced by urethane, a carcinogen that frequently induces K-ras mutations, but only 2 of 6 tumors evaluated had K-ras mutations, which leaves open the possibility that urethane cooperates with Pten loss by inducing somatic mutations of genes other than K-ras. This stands in contrast to our model in which the conditional K-ras and Pten alleles recombined in the same (CCSP-expressing) cells. Hence, the disparate outcomes of these studies might be related to secondary genetic events in the urethane-treated mice or differences in experimental design, such as the genetic backgrounds of the mice or the specific promoter elements driving Cre expression.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Reagents
###end title 46
###begin p 47
###xml 47 53 <span type="species:ncbi:9986">rabbit</span>
###xml 116 120 <span type="species:ncbi:9925">goat</span>
###xml 204 210 <span type="species:ncbi:9986">rabbit</span>
###xml 514 520 <span type="species:ncbi:9986">rabbit</span>
###xml 583 589 <span type="species:ncbi:9986">rabbit</span>
###xml 815 821 <span type="species:ncbi:9986">rabbit</span>
###xml 861 865 <span type="species:ncbi:9925">goat</span>
Antibodies purchased for these studies include rabbit anti-p110alpha (sc-7174), p110beta (sc-7175), SPC (sc-13979), goat anti-CC10 (sc-9772) and PTEN (sc-6818) (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-total AKT (9272), Ser473-phosphorylated AKT (9271), Ser21/9-phosphorylated GSK3alpha/beta (9331), total GSK3 (9332), cleaved caspase-3 (9661), Poly (ADP-ribose) polymerase (9542), phosphorylated-histone H3 (9701), Ser28-phosphorylated histone H3 (9713P) (Cell Signaling Technologies, Danvers, MA), rabbit anti-SPC (WRAB-SPC, Seven Hills Bioreagents, Cincinnati, OH), rabbit anti-CCSP (07-623, Upstate Biotechnologies, Lake Placid, NY), FITC-conjugated anti-Sca-1 (557405), biotin-conjugated anti-CD45 (553771) biotin-conjugated-CD31 (558737), PE-conjugated anti-CD34 (12-0341-33, eBioscience), anti-rabbit IgG Alexa Flour 488 (A11008), and anti-goat IgG Alexa Flour 594 (A11058) (Invitrogen, Carlsbad, CA). Other purchased reagents include streptavidin-APC (554067, BD Pharmigen), TSA kits 22 (T20932), 25 (T20935), and 27(T20937), Avidin/Biotin blocking kit (00-4303) (Invitrogen), Dispase (354235, BD Biosciences), collagenase/dispase (10269638001, Roche Biosciences), and 7-aminoactinomycin D (A1310, Invitrogen).
###end p 47
###begin title 48
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse studies
###end title 48
###begin p 49
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Marsit1">[12]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Wislez1">[24]</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">Mice</span>
To test whether PI3K promotes tumor development, 9 K-rasLA1 mice were treated for 4 weeks with 2 mg/kg/d intra-gastric PX-866, a small molecule inhibitor of PI3K [12], and 12 were given vehicle beginning at 4 months, an age at which lung lesions (AAH and adenomas) are measurable by micro-computed tomography scans. Mice were subjected to these scans at the beginning and completion of treatment to count lesion numbers and evaluate changes in lesion volumes over time as previously reported [24].
###end p 49
###begin p 50
###xml 374 377 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LA1</sup>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL</sup>
###xml 426 430 426 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 496 499 496 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</sup>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 184 188 <span type="species:ncbi:10090">Mice</span>
###xml 287 291 <span type="species:ncbi:10090">Mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
Prior to their initiation, all mouse studies were submitted to and approved by the Institutional Animal Care and Use Committee at the University of Texas-M. D. Anderson Cancer Center. Mice received standards of care and were euthanized according to the standards set forth by the IACUC. Mice and cells and were obtained through collaborations with Dr. Tyler Jacks, MIT (KrasLA1 mice, and KrasLSL mice), Dr. Hong Wu, UCLA (Ptenflox mice), and Dr. Francesco Demayo, Baylor College of Medicine (CCSPCre mice).
###end p 50
###begin title 51
Tissue microarrays and immunohistochemical analyses
###end title 51
###begin p 52
We performed immunohistochemical analysis of PI3K on a tissue microarray containing AAH (n = 17), solid adenomas (n = 31), mixed solid/papillary adenomas (n = 36), papillary adenomas (n = 45), and adenocarcinomas (n = 14) to determine whether the levels of PI3K changed during malignant progression. We analyzed the expression of PI3K isoforms (p110alpha and beta).
###end p 52
###begin p 53
###xml 1386 1390 1366 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Wislez1">[24]</xref>
###xml 706 710 <span type="species:ncbi:9925">goat</span>
###xml 897 901 <span type="species:ncbi:9925">goat</span>
For immunohistochemical staining, 4 mum paraffin-embedded sections were baked at 60degreesC for 30 min and then cooled to ambient temperature. Sections were sequentially incubated in Xylene (5 min twice), 100% ethyl alcohol (5 min twice), 95% ethyl alcohol (5 min twice), and 80% ethyl alcohol (5 min). After washing with water, the sections were antigen-retrieved using citrate buffer (pH 6.0, DAKO) in a steamer for 20 min and cooled to ambient temperature. Sections were then washed with TBS-T and quenched with 3% hydrogen peroxide in TBS for 10 min, blocked for Avidin/Biotin activity, and incubated with primary antibody as follows: For p110alpha and p110beta staining, sections were blocked with 5% goat serum for 1 h, incubated with primary antibodies for 1 h at ambient temperature, and then washed with TBS-T; for Ser28-phosphorylated histone H3 staining, sections were blocked with 10% goat serum at 4degreesC overnight, incubated with primary antibody for 30 min at ambient temperature, and washed with TBS-T. The staining was developed using DAB substrate system. Negative controls included omission of the primary antibody and pre-incubation of primary antibody with blocking peptide. Staining was quantified by one investigator (M.G.R.) blinded as to treatment group. Intra-lesional expression was scored based on staining intensity and extension as described previously [24].
###end p 53
###begin title 54
Detection of BASCs in lung tissues
###end title 54
###begin p 55
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Antigens were retrieved from mouse lung tissues with 0.01 mol/L citrate buffer (pH 6; DakoCytomation, Glostrup, Denmark) for 25 min in a steamer. The slides were quenched in 1.5% hydrogen peroxide in Tris-buffered saline for 10 minutes and blocked in DAKO serum-free protein block (Dako) for 1 h at ambient temperature. The slides were then incubated with anti-SPC (sc-7705, Santa Cruz Biotechnology; WRAB-SPC, Seven Hills Bioreagents) and anti-CCSP (07-623, Upstate Biochemicals) antibodies at 4degreesC overnight. The immunofluorescence was developed using TSA kits 25 and 22 (Invitrogen) on the basis of the manufacturer's instructions. We used blocking peptides and omitted the primary antibodies as negative controls to determine the specificity of the immunostaining results. Immunofluorescence was visualized using a microscope with a reflected fluorescence system (Olympus Model IX71SIF-2). Color acquisition and background fluorescence were optimized by using the DPController and DPManager software (Olympus).
###end p 55
###begin title 56
BASC isolation and culture
###end title 56
###begin p 57
###xml 807 810 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 815 818 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 824 827 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 832 835 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 636 642 <span type="species:ncbi:9913">bovine</span>
###xml 731 736 <span type="species:ncbi:10090">mouse</span>
The mice were killed after 12 weeks, and the lungs were perfused with 10 mL of Hank's balanced salt solution through the right ventricle until they were cleared of blood. The tracheas were injected with Dispase (undiluted liquid, BD Biosciences) followed by 0.5-1 mL 1% LMP agarose in water. The lungs were placed on ice, chopped into pieces, incubated with 0.001% DNAse (Sigma D-4527) and 2 mg/mL of collagenase/dispase (100 mg/mL, Roche) in phosphate-buffered saline at 37degrees C for 45 min, filtered (100 mum followed by 40 mum pore-sized filter), and centrifuged. The resulting pellets were resuspended in 2 mL of PF10 (10% fetal bovine serum in phosphate-buffered saline), which typically yields 1-2 million total cells per mouse. The red cells were lysed. BASCs were isolated by sorting of the Sca-1pos CD45neg Pecamneg CD34pos cell population on a three-laser 13-color FACS Aria fluorescence-activated cell sorter (BD Biosciences) that is capable of sorting four sub-populations at a low pressure with a maximum rate of 20 million cells/hour. BASCs represented approximately 0.1% of the total sorted cell population.
###end p 57
###begin p 58
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 348 354 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
The uniformity or purity of the sorted cells was not routinely checked because the cells of interest would have been consumed in the process. That being said, the cells were sort-purified to the highest possible purity by gating on size (by forward and side scatter), excluding doublets (by forward scatter width versus area and side scatter width versus area), and isolating cells with the markers of interest. In addition, the uniformity of the sorted cell populations used in these assays was reflected by the reproducibility of our findings; the differentiation and colony formation assays were performed each time using cells derived from three different mice, which yielded similar results.
###end p 58
###begin p 59
###xml 609 612 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002220-Kim1">[8]</xref>
###xml 639 642 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 647 650 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 656 659 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 664 667 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
For colony formation assays, the sorted cells were plated in DMEM/HEPES/10% FBS/Pen-Strep/L-glutamine on 96-well plates with feeder cells (irradiated DR4 mouse embryo fibroblasts, SCRC-1045.1, American Type Culture Collection, Manassas, VA) to maintain the undifferentiated state (1000 cells per well). PX-866 was added to the cultures the day following plating. For differentiation assays, BASCs were plated for 7 d on 96-well plates (10,000 cells per well) coated with 100 muL growth factor-reduced Matrigel (356231, BD Biosciences) and subjected to immunofluorescent staining for SPC and CCSP as described [8]. The yield of BASCs (Sca-1pos CD45neg Pecamneg CD34pos) is typically 0.1% of sorted cells from the lung.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
K-ras mutations in non-small-cell lung carcinoma: a review.
###end article-title 61
###begin article-title 62
###xml 59 64 <span type="species:ncbi:9606">human</span>
Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
###end article-title 62
###begin article-title 63
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
###end article-title 63
###begin article-title 64
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.
###end article-title 64
###begin article-title 65
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
###end article-title 65
###begin article-title 66
K-ras activation generates an inflammatory response in lung tumors.
###end article-title 66
###begin article-title 67
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.
###end article-title 67
###begin article-title 68
Identification of bronchioalveolar stem cells in normal lung and lung cancer.
###end article-title 68
###begin article-title 69
Epithelial stem cells of the lung: privileged few or opportunities for many?
###end article-title 69
###begin article-title 70
A negative feedback signaling network underlies oncogene-induced senescence.
###end article-title 70
###begin article-title 71
PTEN: one gene, many syndromes.
###end article-title 71
###begin article-title 72
PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
###end article-title 72
###begin article-title 73
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
###end article-title 73
###begin article-title 74
Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway.
###end article-title 74
###begin article-title 75
Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
###end article-title 75
###begin article-title 76
Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling.
###end article-title 76
###begin article-title 77
###xml 38 44 <span type="species:ncbi:10090">murine</span>
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.
###end article-title 77
###begin article-title 78
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.
###end article-title 78
###begin article-title 79
Identification and expansion of the tumorigenic lung cancer stem cell population.
###end article-title 79
###begin article-title 80
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.
###end article-title 80
###begin article-title 81
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.
###end article-title 81
###begin article-title 82
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.
###end article-title 82
###begin article-title 83
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification.
###end article-title 83
###begin article-title 84
Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
###end article-title 84
###begin p 85
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 85
###begin p 86
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: R01 CA117965, R01 CA105155, U01 CA105352
###end p 86

